Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Can Google Enhance Drug Safety Surveillance?

Executive Summary

Teleconference between company and FDA signals the Internet search giant may have a way to improve adverse event detection.


Related Content

Califf Lowering FDA Drawbridge To Work With External Expertise
Califf Lowering FDA Drawbridge To Work With External Expertise
PDUFA VI: Breakthrough Issues Among FDA Priorities
PatientsLikeMe Pioneers Social Medicine
FDA Acquires Trove Of Rx Safety Data Through Alliance With PatientsLikeMe
FDA’s Twitter Formula Allows Tweets About Products Without Excessive Risks
Social Media Site Could Help FDA Track Adverse Events
Internet Searching May Get ‘Riskier’ For Patients After FDA Citations